16-75545335-A-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001077418.3(TMEM231):​c.582+17T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.253 in 1,603,564 control chromosomes in the GnomAD database, including 52,565 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.26 ( 5240 hom., cov: 27)
Exomes 𝑓: 0.25 ( 47325 hom. )

Consequence

TMEM231
NM_001077418.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.851

Publications

9 publications found
Variant links:
Genes affected
TMEM231 (HGNC:37234): (transmembrane protein 231) This gene encodes a transmembrane protein, which is a component of the B9 complex involved in the formation of the diffusion barrier between the cilia and plasma membrane. Mutations in this gene cause Joubert syndrome (JBTS). Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jan 2013]
TMEM231 Gene-Disease associations (from GenCC):
  • ciliopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Joubert syndrome 20
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • Joubert syndrome with oculorenal defect
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Meckel syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • orofaciodigital syndrome III
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 16-75545335-A-T is Benign according to our data. Variant chr16-75545335-A-T is described in ClinVar as Benign. ClinVar VariationId is 257331.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.278 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TMEM231NM_001077418.3 linkc.582+17T>A intron_variant Intron 4 of 6 ENST00000258173.11 NP_001070886.1
TMEM231NM_001077416.2 linkc.741+17T>A intron_variant Intron 3 of 5 NP_001070884.2
TMEM231NR_074083.2 linkn.748+17T>A intron_variant Intron 4 of 6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TMEM231ENST00000258173.11 linkc.582+17T>A intron_variant Intron 4 of 6 1 NM_001077418.3 ENSP00000258173.5
TMEM231ENST00000568377.5 linkc.669+17T>A intron_variant Intron 3 of 5 1 ENSP00000476267.1
TMEM231ENST00000565067.5 linkc.438+491T>A intron_variant Intron 3 of 5 5 ENSP00000457254.1
ENSG00000260092ENST00000460606.1 linkn.75+17T>A intron_variant Intron 1 of 4 1 ENSP00000457544.1
TMEM231ENST00000562410.5 linkn.*384+17T>A intron_variant Intron 4 of 6 1 ENSP00000454582.1
TMEM231ENST00000570006.5 linkn.544+17T>A intron_variant Intron 4 of 6 5 ENSP00000455520.1

Frequencies

GnomAD3 genomes
AF:
0.259
AC:
39381
AN:
151826
Hom.:
5234
Cov.:
27
show subpopulations
Gnomad AFR
AF:
0.283
Gnomad AMI
AF:
0.349
Gnomad AMR
AF:
0.185
Gnomad ASJ
AF:
0.172
Gnomad EAS
AF:
0.229
Gnomad SAS
AF:
0.228
Gnomad FIN
AF:
0.309
Gnomad MID
AF:
0.316
Gnomad NFE
AF:
0.262
Gnomad OTH
AF:
0.234
GnomAD2 exomes
AF:
0.239
AC:
58635
AN:
245504
AF XY:
0.242
show subpopulations
Gnomad AFR exome
AF:
0.289
Gnomad AMR exome
AF:
0.123
Gnomad ASJ exome
AF:
0.166
Gnomad EAS exome
AF:
0.201
Gnomad FIN exome
AF:
0.307
Gnomad NFE exome
AF:
0.267
Gnomad OTH exome
AF:
0.246
GnomAD4 exome
AF:
0.252
AC:
366354
AN:
1451620
Hom.:
47325
Cov.:
32
AF XY:
0.252
AC XY:
181783
AN XY:
720712
show subpopulations
African (AFR)
AF:
0.286
AC:
9461
AN:
33056
American (AMR)
AF:
0.131
AC:
5690
AN:
43554
Ashkenazi Jewish (ASJ)
AF:
0.174
AC:
4490
AN:
25844
East Asian (EAS)
AF:
0.215
AC:
8492
AN:
39454
South Asian (SAS)
AF:
0.232
AC:
19880
AN:
85708
European-Finnish (FIN)
AF:
0.311
AC:
16578
AN:
53286
Middle Eastern (MID)
AF:
0.232
AC:
1322
AN:
5694
European-Non Finnish (NFE)
AF:
0.258
AC:
285583
AN:
1105152
Other (OTH)
AF:
0.248
AC:
14858
AN:
59872
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
14078
28156
42235
56313
70391
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9534
19068
28602
38136
47670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.259
AC:
39410
AN:
151944
Hom.:
5240
Cov.:
27
AF XY:
0.257
AC XY:
19111
AN XY:
74260
show subpopulations
African (AFR)
AF:
0.283
AC:
11710
AN:
41426
American (AMR)
AF:
0.185
AC:
2822
AN:
15244
Ashkenazi Jewish (ASJ)
AF:
0.172
AC:
598
AN:
3468
East Asian (EAS)
AF:
0.228
AC:
1183
AN:
5178
South Asian (SAS)
AF:
0.227
AC:
1092
AN:
4806
European-Finnish (FIN)
AF:
0.309
AC:
3264
AN:
10552
Middle Eastern (MID)
AF:
0.330
AC:
97
AN:
294
European-Non Finnish (NFE)
AF:
0.262
AC:
17828
AN:
67958
Other (OTH)
AF:
0.236
AC:
499
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1464
2928
4392
5856
7320
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
416
832
1248
1664
2080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.178
Hom.:
540
Bravo
AF:
0.249
Asia WGS
AF:
0.286
AC:
992
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 22, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Joubert syndrome 20 Benign:2
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 28, 2017
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Joubert syndrome 20;C3809352:Meckel syndrome, type 11 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.031
DANN
Benign
0.36
PhyloP100
-0.85
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2738801; hg19: chr16-75579233; COSMIC: COSV50737811; COSMIC: COSV50737811; API